THOMAS STEPHEN BASIL sold 24.4% of their position (50K shares) of CLIMB BIO, INC. on the open market
Open‑market sale worth $350.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/27/2026ACC: 0001193125-26-082533
-50K
Net shares
Net seller
$350.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−33.69K
Price / share
$7.00
Trade value
$235.96K
% of position
16.5%
2/25/2026
204.66K→170.97K
Common Stock
Direct
Shares
−16.31K
Price / share
$7.01
Trade value
$114.29K
% of position
9.5%
2/26/2026
170.97K→154.66K
Total
Net shares
−50K
Net value
-$350.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | S · Sale | −33.69K | $7.00 | $235.96K | 16.5% | 204.66K | 170.97K |
| Common Stock Direct | 2/26/2026 | S · Sale | −16.31K | $7.01 | $114.29K | 9.5% | 170.97K | 154.66K |
| Total | −50K | -$350.25K | ||||||
Derivative Transactions0
No derivative transactions reported